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A 62-year-old male developed ocular ischemic syndrome in his right eye. Carotid angiography and
magnetic resonance angiography revealed total occlusion of the right internal carotid artery and a 53%
occlusion of the left internal carotid artery. The angiographies also revealed a collateral circulation of a
rarely seen reversed blood ﬂow in the right ophthalmic artery, which helped spare the patient from
cerebral stroke. Nevertheless, retinal infarction and neovascularization of the iris, retina, and optic disc
presented with an unrecoverable visual loss. The balance between treating eye ischemia or cerebral
ischemia is a challenge, and timely referral to a neuroradiologist and neurovascular specialist is
important to avoid further serious life-threatening complications.
Copyright  2013, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Cerebral artery “stealing” circulation from the ophthalmic artery
(OA) is rare. The decreased OA perfusion commonly presents with
ocular ischemic syndrome (OIS). The most common etiology of OIS
is atherosclerosis of the carotid artery.1 Typically, a 90% or greater
ipsilateral carotid artery obstruction is necessary for the develop-
ment of OIS.2 The symptoms of OIS include eye pain and vision loss.
Most patients have a gradual onset, but some patients have a
sudden or transient visual loss, also called amaurosis fugax.1,3 Most
of these functional deteriorations are irreversible. The ocular
manifestations include iris neovascularization (NVI), retinochor-
oidal ischemia, and neovascularization of the optic disc or retina.
The clinical signs are similar to diabetic retinopathy and central
retinal vein occlusion, and misdiagnosis or oversight of retinal
angiography is common. Unfortunately, the presence of OIS implies
a risk of cerebrovascular strokewith a 5-year mortality rate of 40%.2
Therefore, OIS is a disease that requires high alertness for prompt
diagnosis. This study reports an uncommon case of unilateral 100%logy, Chang Gung Memorial
ship, Taoyuan County 333,
Hwang).
is manuscript.
e Ophthalmologic Society of Taiwcarotid artery occlusionwith OIS as the initial presentationwithout
cerebrovascular stroke. The angiography revealed an uncommon
reversed ﬂow in the OA to the cerebral cortex, which helped pre-
serve the cerebral cortex from brain infarction.2. Case report
A 62-year-old male smoker with diabetes mellitus and hyper-
tension, who received medication for 5 and 3 years, respectively,
complained of progressively blurred vision in his right eye for 6
months. Ophthalmic examination of his right eye revealed a
decrease in visual acuity to 20/200 and a slight increase in intra-
ocular pressure to 24 mmHg. Slit-lamp biomicroscopy revealed
congested conjunctiva and a clear cornea, but prominent NVI
(Fig. 1A). Fundoscopic examination revealed a diffuse infarction of
the retina with cotton-wool spots, microaneurysms, and retinal
hemorrhages (Fig. 1B). No retinopathy or other abnormal pre-
sentation was observed in the left eye. Fluorescein angiography
revealed a prolonged arteriovenous transit time and delayed cho-
roidal ﬁlling (Fig. 1C) with diffuse retinal arteriovenous leaking
(Fig. 1D). Further systemic evaluation was planned based on our
impression of OIS. Color Doppler imaging of the carotid artery
revealed reversed ﬂow in the right OA (Fig. 2). Carotid angiography
and magnetic resonance angiography revealed total occlusion of
the right internal carotid artery (ICA), 53% occlusion of the left ICAan. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A) External photography revealed dilated conjunctival and episcleral vessels and iris neovascularization [inset is the zoom-in photo for the neovascular iris vessel (arrows)].
(B) Fundoscopic photo revealed a diffuse infarction of the retina with hard exudation, microaneurysms, cotton-wool spots, and retinal dot hemorrhages. (C) Fluorescein angiography
1 minute after injection revealed the delayed choroidal ﬁlling and a delayed arterialevenous transition. (D) The late phase of ﬂuorescein angiography revealed the diffuse vascular
leakage.
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from the left to the right brain. However, one collateral circulation
to the right ICA territory of brainwas noted, which was supplied by
the right external carotid artery via OA anastomosis (Fig. 3).
Accordingly, the patient presented no neurological symptoms in
the 2 years of follow-up, but severe ocular ischemic alterations
were observed in the right eye. The ischemia was treated with
ocular hypotensive agents and panretinal photocoagulation. The
patient was referred to a neurovascular specialist, and thereafterFig. 2. (A) The carotid ultrasound disclosed right ICA total occlusion and (B) moderate ste
ophthalmic artery ﬂow and (D) antegrade ﬂow pattern at the other side. ICA ¼ internal caadopted a comprehensive lifestyle-modiﬁcation strategy, which
included smoking cessation, weight reduction, hypertension con-
trol, blood sugar control, and antiplatelet agents.
3. Discussion
The patient, who had a history of hypertension, diabetes mel-
litus and smoking, exhibited neovascular iridis and ischemic ret-
inopathy. A high intraocular pressure, but lower than expected,nosis (51%) of left ICA. In addition, the patient was also found with (C) reversed right
rotid artery.
Fig. 3. (A) Angiography of right CCA in lateral view revealed complete occlusion of right ICA, resulting opaciﬁcation of branches from right ECA. (B) Angiography of left CCA in AP
view shows normal ICA perfusion, but no contralateral perfusion for right ICA. Subsequent DSA of right CCA in lateral view shows opaciﬁcation of right ophthalmic artery (C, D, blue
arrow) draining into right ICA (D, red arrow) at ophthalmic segment. Further delay subtracted right CCA images in lateral view shows opaciﬁcation of branches of right middle (E,
green arrow) and anterior (E, blue arrow) cerebral arteries. Concentration of contrast medium in right ophthalmic artery is less (E, white arrow) due to ﬂow of contrast medium into
these branches. Left VA angiography in lateral view reveals faint ﬂow to left ICA via left PcomA (F, white arrow). However, the density of contrast medium (F, red arrow) is much
weaker than the ﬂow from the right OA. AP ¼ anterior-posterior; CCA ¼ common carotid artery; DSA¼ digital subtraction angiography; ECA ¼ external carotid artery; ICA ¼ internal
carotid artery; OA ¼ ophthalmic artery; PcomA ¼ posterior communicating artery; VA ¼ vertebral artery.
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a reversed blood ﬂow in the right OA. The collateral blood ﬂow from
the external carotid system to the internal carotid system aided
cerebral perfusion. Accordingly, the patient had visual morbidity in
the ischemic eye but no further neurovascular consequence in the
past 2 years.
OIS is deﬁned as a symptomatic carotid disease that occurs at a
mean age of about 63e68 years.3,4 The most common etiology is
atherosclerosis of the carotid artery.1 Approximately 22% of
patients have bilateral carotid artery stenosis.1,4e6 Associated sys-
temic diseases include arterial hypertension, diabetes mellitus,
coronary artery disease, previous cerebrovascular accident or
transient ischemic attract, and peripheral vascular disease.2e4 Our
patient was in this high-risk group.
Patients with OIS demonstrate decreased blood ﬂow in retro-
bulbar vessels and the OA.7,8 OA steals blood ﬂow away from the
eye to the low-resistance intracranial circuit, which leads to
hypoperfusion and ischemia in ocular tissues.8,9 Total occlusion of
the right ICA in our case created a pressure gradient between the
right external carotid artery and the OA, which created an OA
stealing phenomenon to the collateral brain circulation. Although
the patient lost vision in the right eye, the sufﬁcient collateral cir-
culation saved the patient from a life-threatening cerebrovascular
accident or the presentation of any other neurological symptoms or
signs.
Ocular treatments of OIS concentrate on the control of asso-
ciated complications and include topical steroids for the ocular
inﬂammation, ocular hypotensive agents to reduce the intraocular
pressure, panretinal photocoagulations for NVI and the neo-
vascularization of the optic disc or retina, and intravitreal anti-
vascular endothelial growth factor biologics for neovascularglaucoma or NVI.10e13 Surgical procedures for carotid stenosis are
not appropriate for patients with chronic total occlusion.14
OIS patients have a 5-year mortality rate of approximately 40%.2
The most common causes of death are brain stroke and coronary
artery disease.2 Patients with carotid artery disease with ocular
symptoms portend a lower risk of ipsilateral stroke than hemi-
spheric transient ischemic attack.15 Although legally blind in the
right eye, our patient had not suffered from vascular insult, such as
stroke or cardiac disease, after the lifestyle modiﬁcation and
medical treatments during the 2-year follow-up.
Risk modiﬁcation and aggressive medical therapy is essential
for all symptomatic patients with carotid artery disease, including
antiplatelet agents, statin agents, and treatment for underlying
diseases, such as hypertension and diabetes mellitus.14 The current
treatment guidelines of the American Heart Association/American
Stroke Association (2011) for the treatment of symptomatic carotid
artery disease suggest the following. First, carotid artery endar-
terectomy (CEA) is recommended for patients with 50e99% car-
otid artery stenosis if the perioperative morbidity and mortality
risk is less than 6%. Second, carotid artery stenting (CAS) is indi-
cated as an alternative to CEA for patients with >70% carotid
artery stenosis by noninvasive imaging or >50% carotid artery
stenosis by catheter angiography if the patient is at an average or
low risk of complications with endovascular intervention. Third,
CEA or CAS is not indicated for patients with <50% carotid
stenosis. Fourth, CEA or CAS is not recommended for patients with
chronic total occlusion of the targeted carotid artery.14 Never-
theless, our patient had no neurological morbidity in the 2 years of
observation. Our patient was hesitant to undergo carotid surgical
management because of the high risk of cerebral reperfusion
damage.
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rological morbidity/mortality. Reversed blood ﬂow in the OA is
uncommon but represents the speciﬁc phenomenon of blood
stealing, which sacriﬁces the ocular tissue for the preservation of
the cerebral cortex. Ophthalmologists should use caution in
patients with ischemic ocular presentation, which implies a dev-
astating underlying disease. Ophthalmologists play an important
role in the early diagnosis and proper arrangement of the systemic
evaluation for the detection of the latent underlying disease. Timely
referral to a neurovascular specialist and radiologist is necessary to
avoid serious life-threatening complications, such as cere-
brovascular accidents or coronary artery disease.
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